Company Filing History:
4 out of 61 
1 out of 1,373 
1 out of 413 
Years Active: 2014-2018
Title: Innovations by Jeremy Duffield
Introduction
Jeremy Duffield is an accomplished inventor based in Seattle, WA. He holds a total of 6 patents that focus on significant advancements in medical treatments. His work primarily addresses critical health issues, particularly in the field of kidney diseases.
Latest Patents
Among his latest patents is a method for the treatment of Alport Syndrome. This patent outlines the use of modified oligonucleotides targeted to miR-21, which have shown promise in improving kidney function and reducing fibrosis in affected subjects. Additionally, these modified oligonucleotides may delay the onset of end-stage renal disease and the need for dialysis or kidney transplants in patients with Alport Syndrome. Another notable patent involves the administration of DKK1 muteins to treat fibrosis. This patent provides methods for treating scarring in organs by modulating various signaling pathways, including WNT and TGF-beta.
Career Highlights
Jeremy has worked with notable companies such as Regulus Therapeutics Inc. and Regulus Therapeutics Inc. His contributions to these organizations have been instrumental in advancing research and development in therapeutic solutions.
Collaborations
Throughout his career, Jeremy has collaborated with esteemed colleagues, including Balkrishen Bhat and Deidre A MacKenna. These partnerships have fostered innovation and enhanced the impact of his work in the medical field.
Conclusion
Jeremy Duffield's innovative contributions to medical science, particularly in the treatment of kidney diseases, highlight his role as a significant inventor. His patents reflect a commitment to improving patient outcomes and advancing healthcare solutions.